Filing Details

Accession Number:
0001209191-20-058367
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-13 18:13:14
Reporting Period:
2020-11-10
Accepted Time:
2020-11-13 18:13:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1435049 Chinook Therapeutics Inc. KDNY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202785 Eric Dobmeier C/O Chinook Therapeutics, Inc.
1600 Fairview Ave. E.
Seattle WA 98102
President, Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-10 2,000 $13.86 48,337 No 4 P Direct
Common Stock Acquisiton 2020-11-11 2,500 $13.75 50,837 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.75 to $14.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
  2. Certain of the shares are subject to forfeiture to the Issuer if underlying vesting conditions are not met.
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.65 to $13.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.